BlackRock Amends CONMED Stake, Files 19th SC 13G/A
Ticker: CNMD · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 816956
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock updated its CONMED holdings, still a major player.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, indicating a change in their ownership of CONMED Corp. common stock as of December 31, 2023. This amendment, the 19th for BlackRock regarding CONMED, shows that BlackRock continues to be a significant institutional holder, which can provide a sense of stability for investors. For shareholders, this filing confirms that a major institutional investor maintains a substantial, albeit potentially adjusted, stake in CONMED, signaling continued institutional confidence or at least ongoing monitoring of the company.
Why It Matters
This filing shows that BlackRock, a major institutional investor, is still a significant shareholder in CONMED Corp., which can influence investor perception and stock stability.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note that a major institutional investor like BlackRock continues to monitor and adjust its position in CONMED, suggesting ongoing institutional interest. This filing itself doesn't warrant immediate action but reinforces the need to track CONMED's performance and BlackRock's future filings for any significant changes in their stake.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- CONMED Corp. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
- 19 (number) — the amendment number for this filing
Forward-Looking Statements
- BlackRock will continue to hold a significant stake in CONMED Corp. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 19)' sections.
Who is the 'Subject Company' in this filing?
The 'Subject Company' is CONMED Corp., as indicated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CONMED Corp'.
Who is the 'Filed By' entity in this document?
The 'Filed By' entity is BlackRock Inc., as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as explicitly mentioned in the filing.
What is the CUSIP Number for the securities reported?
The CUSIP Number for the Common Stock of CONMED Corporation is 207410101, as listed under 'CUSIP No. 207410101'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding CONMED Corp (CNMD).